Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Payment
January 09, 2019 11:00 PM

Congress revives flurry of drug pricing legislation

Susannah Luthi
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Pixabay

    Lawmakers rushed into the drug pricing arena this week as they revived a bundle of legislation and oversight talks, signaling they want to put manufacturers in the hot seat when it comes to addressing healthcare costs.

    Medicare negotiation was at the forefront of Democratic messaging with an unexpected Republican boost. Rep. Tom Rooney (R-Fla.) joined Rep. Peter Welch (D-Vt.) to re-introduce legislation to allow the HHS secretary to directly barter with manufacturers on behalf of Medicare Part D. Rooney is the sole Republican to co-sponsor the bill so far.

    On Thursday, Sen. Amy Klobuchar (D-Minn.) revived the upper chamber's companion bill as Sen. Bernie Sanders (I-Vt.) held a press conference to tout this and other measures, promising an end to pharma "greed."

    But it's unclear how aggressively Congress will end up legislating on the issue and how lawmaker action will play into HHS Secretary Alex Azar's proposal to tie Medicare Part B prices to the lower prices paid in other comparable countries.

    One of the decisive figures in the upper chamber, Senate Finance Committee Chuck Grassley (R-Iowa), told reporters on Wednesday that he remains opposed to direct government negotiation despite other vast areas where he sees himself working with Democrats on drug prices.

    A key architect of the law that created Medicare Part D in 2003, Grassley said he will prioritize policies to modernize the program, with an eye on how manufacturers might be gaming the current system. But he emphasized that he doesn't want direct government negotiation with the private sector and doesn't see the need as Part D has consistently come in under budget.

    "Going back for a full 10 years, [Part D] has basically come in under budget by about 40%," he said. "If it's working, don't mess with it."

    But Grassley has yet to take a firm position on Azar's proposal for the international price index for Part B, telling reporters that he will discuss the policy with the secretary after the public comment period closes.

    "Initially, I don't want foreign countries to set our drug prices," he said. "What can he do to modify that so that principle is not violated?"

    Related to Azar's proposal, Sanders introduced his own coordinated effort with Rep. Ro Khanna (D-Calif.) that would make the international benchmark policy law. Sanders promised he would do so at the end of last Congress.

    Lawmakers also paved the way for industry oversight, as Grassley made it clear he will focus on anticompetitive issues with drugmakers.

    He joins other key lawmakers with oversight jurisdiction. House Oversight Committee Chair Elijah Cummings, a Maryland Democrat, on Thursday announced that his first hearing scheduled for Jan. 29 will focus on high drug prices.

    Rep. Raja Krishnamoorthi (D-Ill.), who chairs the health subcommittee for oversight, told Modern Healthcare that he expects to call pharmaceutical executives before the panel as well.

    Grassley threw his support for three additional bills that didn't make it through the last Congress. He is sponsoring a measure with Klobuchar to crack-down on manufacturer pay-to-delay tactics that stall generics from entering the market. The two senators also are reviving a measure championed by the late Sen. John McCain to allow people to import prescription drugs from Canada for their personal use.

    He also plans to move the Creates Act, a joint effort with Sen. Patrick Leahy (D-Vt.) that passed out of the Senate Judiciary Committee last summer. Creates Act aims at expediting generic drugs and biosimilars to market but has faced opposition from the pharmaceutical trade group.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Ambulance blur
    Most ambulance rides out-of-network, FAIR Health reports
    Hospital systems finance 3
    CMS unveils new payment model targeting population health
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing